These results offer a mouse model for use in future mechanistic studies of EGPA, and they suggest that IL-33, ILC2s, and IL4Rα signaling may be potential targets for further study and therapeutic targeting in patients with EGPA. This evidence concerns the gene IL4R and eosinophilic granulomatosis with polyangiitis.